Benitec Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNTC and other ETFs, options, and stocks.About BNTC
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firms' proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration.
BNTC Key Statistics
BNTC News
JMP Securities raised the firm’s price target on Benitec Biopharma to $16 from $10 and keeps an Outperform rating on the shares. Results with BB-301 in a first...
An update from Benitec Biopharma Ltd (BNTC) is now available. Benitec Biopharma Inc. has entered into a Securities Purchase Agreement on April 17, 2024, with s...
Loading... Loading... Thursday, Benitec Biopharma Inc BNTC released interim clinical data from the 90-day timepoint following the administration of BB-301 to t...
More BNTC News
An update from Benitec Biopharma Ltd (BNTC) is now available. Benitec Biopharma Inc. announced promising interim results from its BB-301 Phase 1b/2a clinical t...
Benitec Biopharma announces positive interim clinical data from the 90-day timepoint following the administration of BB-301 to the study’s first subject treated...
Benitec Biopharma Inc. -First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~1...
Clinical-stage, gene therapy-focused, biotechnology company, Benitec Biopharma ( NASDAQ: BNTC stock price climbed 33% during pre-market hours of trading on Thur...
Benitec Biopharma announced a $40M private investment in public equity financing from the sale of 5,749,152 shares of its common stock at a price per share of $...